Titan Pharmaceuticals Announces Journal Of The American Medical Association Publication Of Phase 3 Probuphine™ Data

Titan Pharmaceuticals Announces Journal Of The American Medical Association Publication Of Phase 3 Probuphine™ Data
Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA)…
Read more on Medical News Today

Calgary Takes the Lead to Re-House and Support Those Leaving Treatment Programs
CALGARY, ALBERTA– (Marketwire – Oct. 12, 2010) – Calgary agencies are again taking the lead on ending homelessness, with a unique program to re-house and support 75 individuals who would otherwise have been homeless upon completing substance abuse and addictions treatment. The Calgary Homeless Foundation and Housing and Urban Affairs are contributing $ 785,000 to this program, led by Fresh Start …
Read more on Marketwire